. DOD2019/004 February 20, 2019 Subject: Management’s discussion and analysis of the Company’s operating results for the year 2018 period To: President The Stock Exchange of Thailand DOD Biotech Public
/2561 November 12, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q3/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
the Subsidiary is completed, the company will announce the news via the Stock Exchange of Thailand. 2. Related Parties and the Relationship with the Listed Company Vacant Land Buyer : DOD Biotech Public
/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public
/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
accounting and approval of the disposal of investmentsBS Myco Biotech Company Limited ( 2 st review) 28/12/2021 19:33 Notification of the resignation of the Company's director and appointment of a supervisor
/2018 December 19, 2018 Re: Notification of Resolutions of the Board of Directors’ Meeting No. 8/2018 Attn.: President The Stock Exchange of Thailand Enclosure 1. Information Memorandum on Acquisition of
- Translation- July 11, 2019 Subject: Notification the disposition of investment in shares. (Revised) To: Director and Manager The Stock Exchange of Thailand Eureka Design Public Company Limited (the “Company